-

Form 8.3 - International Paper Company

LONDON--(BUSINESS WIRE)-- 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

International Paper Company

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

31-07-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes - DS Smith plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

Common Stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.0

7,101,148

2.04

(2) Cash-settled derivatives:

 

0

0.0

0

0.0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

400,000

0.11

0

0

 

TOTAL:

400,000

0.11

7,101,148

2.04

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

Common Stock

Sale

5

46.18

Common Stock

Sale

6

46.10

Common Stock

Sale

22

46.01

Common Stock

Sale

25

46.44

Common Stock

Sale

55

46.12

Common Stock

Sale

61

46.50

Common Stock

Sale

79

46.00

Common Stock

Sale

90

46.41

Common Stock

Sale

100

45.84

Common Stock

Sale

100

45.98

Common Stock

Sale

117

46.54

Common Stock

Sale

124

46.42

Common Stock

Sale

130

46.55

Common Stock

Sale

156

46.16

Common Stock

Sale

157

46.14

Common Stock

Sale

167

46.45

Common Stock

Sale

251

46.15

Common Stock

Sale

285

46.07

Common Stock

Sale

322

46.51

Common Stock

Sale

400

46.55

Common Stock

Sale

1649

46.26

Common Stock

Sale

9200

46.48

Common Stock

Purchase

1

45.98

Common Stock

Purchase

10

46.69

Common Stock

Purchase

49

46.08

Common Stock

Purchase

51

46.15

Common Stock

Purchase

61

46.59

Common Stock

Purchase

65

45.84

Common Stock

Purchase

75

45.94

Common Stock

Purchase

79

46.36

Common Stock

Purchase

81

45.86

Common Stock

Purchase

86

46.45

Common Stock

Purchase

87

46.05

Common Stock

Purchase

100

45.95

Common Stock

Purchase

100

46.04

Common Stock

Purchase

100

46.34

Common Stock

Purchase

100

46.52

Common Stock

Purchase

102

46.48

Common Stock

Purchase

108

45.79

Common Stock

Purchase

108

46.39

Common Stock

Purchase

123

45.80

Common Stock

Purchase

126

45.89

Common Stock

Purchase

140

46.55

Common Stock

Purchase

154

46.51

Common Stock

Purchase

174

46.65

Common Stock

Purchase

190

45.93

Common Stock

Purchase

200

45.90

Common Stock

Purchase

200

46.06

Common Stock

Purchase

200

46.12

Common Stock

Purchase

230

46.68

Common Stock

Purchase

252

45.85

Common Stock

Purchase

262

46.38

Common Stock

Purchase

273

46.42

Common Stock

Purchase

277

46.02

Common Stock

Purchase

290

46.06

Common Stock

Purchase

296

46.43

Common Stock

Purchase

308

46.57

Common Stock

Purchase

316

46.46

Common Stock

Purchase

317

46.33

Common Stock

Purchase

336

45.82

Common Stock

Purchase

359

46.07

Common Stock

Purchase

392

46.49

Common Stock

Purchase

396

46.63

Common Stock

Purchase

401

45.88

Common Stock

Purchase

438

45.87

Common Stock

Purchase

443

46.54

Common Stock

Purchase

448

46.55

Common Stock

Purchase

466

45.92

Common Stock

Purchase

504

45.83

Common Stock

Purchase

507

46.41

Common Stock

Purchase

530

46.28

Common Stock

Purchase

549

46.64

Common Stock

Purchase

556

46.53

Common Stock

Purchase

566

45.96

Common Stock

Purchase

575

45.95

Common Stock

Purchase

581

45.91

Common Stock

Purchase

603

45.99

Common Stock

Purchase

604

46.67

Common Stock

Purchase

626

45.81

Common Stock

Purchase

678

46.60

Common Stock

Purchase

721

46.09

Common Stock

Purchase

727

45.97

Common Stock

Purchase

727

46.24

Common Stock

Purchase

837

46.47

Common Stock

Purchase

928

46.43

Common Stock

Purchase

958

46.19

Common Stock

Purchase

1009

46.10

Common Stock

Purchase

1073

46.04

Common Stock

Purchase

1112

46.58

Common Stock

Purchase

1180

46.61

Common Stock

Purchase

1181

46.13

Common Stock

Purchase

1222

46.22

Common Stock

Purchase

1237

46.51

Common Stock

Purchase

1276

46.59

Common Stock

Purchase

1403

46.25

Common Stock

Purchase

1420

46.12

Common Stock

Purchase

1521

46.23

Common Stock

Purchase

1578

46.50

Common Stock

Purchase

1854

46.00

Common Stock

Purchase

1867

46.17

Common Stock

Purchase

1935

46.11

Common Stock

Purchase

1945

46.56

Common Stock

Purchase

2100

46.26

Common Stock

Purchase

2170

46.05

Common Stock

Purchase

2239

46.15

Common Stock

Purchase

2478

46.01

Common Stock

Purchase

2533

46.14

Common Stock

Purchase

2634

46.49

Common Stock

Purchase

2714

46.21

Common Stock

Purchase

2820

46.20

Common Stock

Purchase

3053

46.02

Common Stock

Purchase

3192

45.98

Common Stock

Purchase

3206

46.18

Common Stock

Purchase

3579

46.52

Common Stock

Purchase

3835

46.03

Common Stock

Purchase

3990

46.62

Common Stock

Purchase

5037

46.16

Common Stock

Purchase

69380

46.48

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (USD)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (USD)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

 

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

01-08-2024

Contact name:

Stuart Brown

Telephone number:

00442070722969

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure:

Qube Research & Technologies Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

International Paper Company

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Common Stock

Call option

IP US 09/20/24 C50 Equity

Purchase

120,000

USD 50

American

09/20/24

Common Stock

Call Option

IP US 09/20/24 C50 Equity

Purchase

280,000

USD 50

American

09/20/24

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Contacts

Qube Research & Technologies LTD

Qube Research & Technologies LTD

LSE:0JCB

Release Versions

Contacts

Qube Research & Technologies LTD

More News From Qube Research & Technologies LTD

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
Back to Newsroom